Our results show that the E3 ligase, ubiquitin conjugation factor E4 A (UBE4A) targets PCBP1 for proteasomal degradation and that UBE4A expression can serve as a novel biomarker in thyroid cancer patients. The gene discussed is UBE4A; the disease is thyroid cancer.